Lung inflammation and injury can quickly turn into acute respiratory distress syndrome (ARDS) in patients with pneumonia, COVID-19 and other conditions.

MiNK Therapeutics (NASDAQ:INKT) said it initiated dosing in a randomized Phase II trial of its allogeneic invariant natural killer T-cell therapy, agenT-797, for patients with acute lung injury and ...

Researchers at the University at Buffalo are testing omega-3-based nanomedicine in mice to boost inflammation-resolving ...

New research suggests that thistle, long known as a medicinal plant that supports liver health, may also help prevent acute ...

"Severe respiratory infection remains a significant source of pediatric morbidity, even in the postpandemic era," says Maria ...

Pune: Covid-19 infections — largely mild initially — are increasingly triggering moderate to moderately severe illness, while H1N1 influenza has emerged as the more serious respiratory infection this ...

According to MarketsandMarkets™, the Ventilators Market is projected to reach USD 3.10 billion by 2031 from USD 2.49 billion ...

A patient with Duchenne muscular dystrophy died after receiving a gene-editing therapy in China, sparking new concerns about regulatory oversight and transparency as China seeks to cement its position ...

According to MarketsandMarkets, the Ventilators Market is projected to reach USD 3.10 billion by 2031 from USD 2.49 billion in 2026, at a CAGR ...

The COVID-19 pandemic highlighted some severe consequences of unchecked respiratory disease, including cytokine storm.

Polish and US researchers have found a way to stop a destructive form of cell death after it has already begun.